Alternatives to Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. is a Contract Research Organization tool: a global contract research organization providing essential drug discovery and development services. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
Charles River Laboratories International, Inc. profileMore Contract Research Organization alternatives
The 20 closest Contract Research Organization companies to Charles River Laboratories International, Inc.
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
- Website
WuXi AppTec66Drug DiscoveryShanghai, China$40.0MGlobal CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.
- Website
Alagene38Life SciencesRehovot, IsraelIsrael's leading bio-foundry for synthetic biology innovation, spanning ideation to proof-of-concept.
- Website
IQVIA18HealthcareDurham, United StatesLeveraging AI and advanced analytics to drive innovation in healthcare and life sciences.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website
Verdiva Bio54BiotechnologySan Diego, United States$170.0MClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website COContraline48BiotechnologyCharlottesville, USA$102.5M
Developing novel male contraceptives.
- Website
Curia67Contract Research OrganizationAlbany, United States$56.3MGlobal contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries.
- Website
Turn Therapeutics38BiotechnologyLos Angeles, USA$25.0MA clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Elicit62Artificial IntelligenceOakland, United States$31.0MAI-powered research assistant for scientific literature review and data extraction.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Algorithmiq60Quantum ComputingHelsinki, Finland$38.1MQuantum software company enabling breakthroughs in chemistry, materials science, and life sciences.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8MA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
Showing the 20 closest matches. See the rest on the Charles River Laboratories International, Inc. profile.
Compare Charles River Laboratories International, Inc. head to head
Side by side on what each one does, what it costs, and what real users report.